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Abstract
Background: Human Papillomavirus (HPV) is well known pathogen that can cause benign and malignant tumors in
humans, yet there is very little information regarding HPV types prevalent in Pakistan.
Methods: A total of 92 cervical secretions were collected from suspected married female patients and used for
DNA isolation using a novel isolation method. The samples were tested through Polymerase Chain Reaction (PCR)
using already reported primers MY09/MY11, GP5/GP6, GP5+/GP6+, CP65/CP70, CP66/CP69 and SPF1/SPF2 and with
those developed in this study including HRT1 and HRT2 primer sets for typing HPV types and HACTB primer set for
human beta actin gene as internal positive control. Sequencing and phylogenetic analyses were performed for two
isolates to determine circulating HPV types.
Results: PCR with HRT1 and HRT2 indicated 2 (2.17 %) patients were positive for HPV type- 16 while 1 (1.08 %) with
HPV type 18. Sequencing and phylogenetic analysis of isolates confirmed HPV type-16 in genus alpha 9 which have
99 % homology with already reported HPV from Japan and Costa Rica.
Conclusion: This is the first report of HPV type-16 genus alpha 9 in Pakistan and the reported assay and sequence
data will serve as valuable tools in further epidemiological studies for HPV surveillance to improve public health,
especially of females in Pakistan.
Keywords: Cervical carcinoma, Sexually Transmitted Diseases, Papillomavirus, Phylogenetic, Molecular epidemiology
Background
Human papillomaviruses (HPVs) are diverse, non-
enveloped, double stranded DNA viruses which are
sexually transmitted and belong to family Papillomaviri-
dae. The family Papillomaviridae is very large and con-
tains 16 genera [1] with virus species which infects
humans, non-human mammals and reptiles. More than
120 species of this family infect humans belonging to
five genera including Alphapapillomavirus, Betapapillo-
mavirus, Gammapapillomavirus, Mupapillomaviurs and
Nupapillomavirus of which genus Alphapapillomavirus
is the biggest. About fifteen HPV types including HPV-
16, −31, −33, −35, −52, −58, (belonging to species Human
papillomavirus 16), −18, −39, −45, −59, −68, (Human
papillomavirus 18), −51, −82 (Human papillomavirus
26) −73 (Human papillomavirus 34) and −56 (Human
papillomavirus 53) [1] are considered “high risk” due
to their association with malignant transformation [2, 3].
The HPV type-16, followed by HPV type-18 are reported
to be associated with 70 % of invasive cervical cancer
worldwide [4].
Infection with human papillomaviruses is directly as-
sociated with ano-genital cancer in both males and fe-
males [5, 6]. The cervical cancer associated with HPV
infection is the second most common cancer in women
worldwide, with 8.2 % mortality rate [7], and is the
major cancer of women in most of the developing coun-
tries [8] where majority of the cervical cancer cases
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occur [7] due to the lack of health facilities to diagnose
and treat the disease. Pakistan is one of the developing
countries where social and religious taboos, the stigma
associated with sexually transmitted diseases (STDs),
and economic barriers are major hurdles in the fight
against STDs. Furthermore, the awareness of STIs
among sex-workers especially, and among nursing staff
and interns in tertiary-care hospitals, in general [9] is al-
most zilch. The social demographics warrant wide
spread epidemic of STIs in general population of
Pakistan [10, 11] as anticipated for Human immunodefi-
ciency virus (HIV) [12, 13].
HPV infection has been implicated in carcinomas of
cervix [14–16], oral cavity [17] and lungs [18] in
Pakistan as well as its DNA has been detected in general
population [15, 19]. The studies aiming to investigate
prevalence of HPV utilize general primers for detection
of HPV DNA. Currently most commonly used universal
primers for HPV types are MY09/MY11 [20], GP5/GP6
[21], GP5+/GP6+ [22], CP65/CP70, CP66/CP69 [23],
and SPF1/SPF2 [24] designed during 1990s or earlier.
These primers were designed when sequence data of
many of the currently known HPV genomes were not
available as well as computation algorithm and power to
reveal genome wide conserved regions were also not suf-
ficiently advanced. Therefore, need existed to develop
primers based on more rigorous analyses with larger se-
quence dataset which can not only detect more HPV
types as well as can amplify sufficient proportion of
HPV genome suitable for sequencing and phylogenetic
analysis for rigorous confirmation of infecting type. Here
we describe the development of a cheap method for
HPV DNA isolation from small quantities of cervical se-
cretions and novel primers designed for quality amplifi-
cation of high risk HPV types. We also reported the
sequence and phylogenetic analysis of two HPV isolates
from Pakistan, which provided baseline information of
molecular epidemiology of HPV in Pakistan.
Results
The DNA isolation method developed in this study con-
sistently isolated about 0.5 to 1.0 μg of DNA from cer-
vical secretions with values greater than 1.7 for
absorbance ratio of 260/280 nm. The PCR analyses indi-
cated that of 92 suspected married female patients of di-
verse age group and ethnicity, only 2 (2.17 %) patients
tested positive for HPV type-16, while 1 (1.08 %) was
tested positive with HPV Type 18. The PCR amplifica-
tion with already reported primer sets MY09/MY11,
GP5/GP6, GP5+/GP6+, CP65/CP70, CP66/CP69, and
SPF1/SPF2 were performed but showed no positive re-
sult, although the human actin beta gene was positively
amplified using HACTB primer set. When these samples
were tested with HRT1 and HRT2 novel primer sets, 3
out of 92 samples were found positive for HPV, two with
HRT1 while other from HRT2 primer sets. Two out of
these three positive samples were from a subset of two
patients that were later diagnosed with cervical carcin-
oma, indicating a positivity of 100 % (2 out of 2) in pa-
tients with cervical carcinoma. The positive samples
using HRT1 were further cloned and sequenced which is
deposited in the GenBank through accession number
JX073135 and KU212390 under the name of HPV Pak01
and HPV Pak02 isolates respectively, while sample posi-
tive using HRT2 was not sequenced due to paucity of
the infected DNA.
The sequence analysis of 1461 bp fragment amplified
by HRT1 primer set, of both Pak01 and Pak02, indicates
that both are more than 99 % identical to each other
with only one synonymous mutation at 426 nt from G
in Pak01 to A in Pak02. The phylogenetic analysis with
sequences of other HPV types, revealed that both the
isolates clusters with 100 % bootstrap support with HPV
type 16 reference sequence [25], among HPV 16 species
(Fig. 1a) in genus alpha 9 (α9) [26]. Their relationship
with other HPV type 16 isolates were further determined
by BLAST analysis [27]. All the sequences of HPV 16
with full sequence coverage in BLAST analysis were ex-
tracted from GenBank and used for phylogenetic ana-
lysis (Fig. 1b). The phylogenetic analysis HPV 16 isolates
indicated that HPV Pak01 and Pak02 clustered with
85 % bootstrap value and more than 99 % homology
with isolates JP0278 and Qv00512 originated reportedly
form Japan [28] and Costa Rica [29] respectively.
Discussion
Pakistan with a population of more than 180 million ac-
cording to Population Census Organization of Pakistan
(http://www.pbs.gov.pk/content/population-census) is
the sixth most populous country in the world. Breast
cancer is one of the most common cancers in the coun-
try with 13.8 % incidence and 10.2 % mortality followed
by cervical cancer with 8.4 % incidence and 7.2 % mor-
tality [7]. In current study we detected HPV in 3.26 % of
cases with gynecological problems, later on two of these
three positive patients were diagnosed cervical cancer.
Previously, the HPV positivity of 2.8 % in general popu-
lation, 27.3 % in patient with cervical abnormalities [15]
and 18 % [16] to 98.33 % [14, 30] in cervical carcinoma
patient has been reported for Pakistani population. Only,
the primers sets (HRT1 & HTR2) developed in this
study showed positive results as compared to previously
reported universal primers designed during 1990s.
HPV infection has been implicated in breast [1, 31]
and cervical cancers [32, 33]. The detection of HPV
types in cancer is commonly done by different PCR as-
says which utilize various universal primers including
MY09/MY11 [20], GP5/GP6 [21], GP5+/GP6+ [22],
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CP65/CP70, CP66/CP69 [23], and SPF1/SPF2 [24] de-
signed during 1990s or earlier. The specificities of these
assays differ towards different types [34–36], which pose
inconsistencies in detection and accurate determination
of prevalence of various HPV types [34, 37, 38]. These
inconsistencies might be one of the factors in the con-
troversial reports of the presence of HPV in malignant
tumors by some studies [5, 39–44] and absence by
others,[45–48]. Therefore, development of primers cap-
able of detecting more types is a crucial need. In
addition, for epidemiological purposes it is of great
importance to know the genetic sequence variability as-
sociated with virus population in that particular demo-
graphic and geographic region. These universal primers
produce PCR products of less than 500 bp which is not
sufficient for phylogenetic based confirmation in particu-
lar for HPV which have low mutation [49] but signifi-
cant recombination rates [50].
The HRT1 and HRT2 primer sets developed in this
study are based on more rigorous analyses with larger
sequence data set compared to already developed
primers. An in-silico analysis using BLAST searches in
non-redundant database indicated that both these pri-
mer set together can theoretically amplify about nine
different HPV types belonging to high risk category, while
the other primer sets are only capable of theoretically de-
tecting seven (MY09/MY11) and four (GP5+/GP6+) high
risk HPV types (Table 1). Interestingly, GP5 primer was
not even been matched to any HPV sequence present in
non-redundant database. These and other primers pre-
sented in Table 1 produce a PCR product of less than
500 bp except HRT1 and HRT2 primer sets which target
a region of about 1460 bp and about 1200 bp respectively
and provide sufficient sequence information to perform
phylogenetic analysis for elucidation of HPV type reliably.
Although thorough analysis with larger data set is re-
quired for an empirical comparison, nevertheless theoret-
ical comparison using BLAST searchers and positive PCR
amplification of two samples which were shown negative
with previously reported primers, indicates the usefulness
of these primer in HPV detection, specifically in those
geographical regions where lack of information about
genetic structure of circulating HPV types exists, such
as Pakistan.
In population of Pakistan, although studies have been
reported for the detection of HPV with in situ
hybridization assay [51] and by PCR assay using univer-
sal primers [14–18, 30], sequence of any isolate and
Fig. 1 Phylogenetic analyses of HPV isolate Pak01. a. The radiating NJ tree of HPV Pak01 and Pak02 with other HPV types having full-length genome
sequences available from GenBank was constructed using MEGA version 5.05 [57]. The HPV Pak01 and Pak02 isolates (highlighted in gray) cluster with
HPV type 16 reference sequence (accession no. NC_001526.2) with 100 % bootstrap support, in HPV16 species which include HPV types 16, 31, 35, 33,
52, 58 and 67 [1] and collectively belongs to α9 in genus alpha [26]. The annotation of species and genera in the tree follows Bernard and colleagues
[26]. The bar indicates substitutions per site. b. The circular NJ tree was generated by phylogenetic analysis of HPV Pak01 and Pak02 with HPV 16
isolates having full-length genome sequences available from GenBank. The HPV Pak01 and Pak02 isolate (highlighted in gray) clusters with HPV type
16 isolates JP02789 from Japan and Qv00512 from Costa Rica [29]. The bracket parenthesis indicates substitutions per site
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confirmation of circulating HPV types by sequencing
and phylogenetic analysis was never reported. The
phylogenetic analysis of current study confirmed that
isolate Pak01 from a female patient suffering from cer-
vical cancer and Pak02 from a female in Gujrat, belong
to HPV type-16, and falls under Human papillomavirus
16 species in genus alpha 9 of Papillomaviridae. The
close phylogenetic relationship and 99 % nucleotide
identity of these isolates with isolates from Japan and
Costa Rica [29] indicate the probable role of expatriates
in the spread of HPV across the world. The role of expa-
triates in spreading STIs such as HIV has been already
been reported [52, 53] which had lead HIV to a verge of
big epidemic in Pakistan [12].
The majority of population in Pakistan is living in poor
socio-economic demography with little accessibility to
quality medical care. In addition, social and religious ta-
boos and stigma associated with sexually transmitted
diseases offer great hindrance in studying and man-
aging STIs. The studies on STIs with tracing of infec-
tion origin through phylogenetic analysis can help in
identify the active transmitting group as well as risk
groups and may lead pinpoint interventions for early
diagnosis and blocking of disease transmission to
healthy population.
Methods
In this study 92 married female patients that were sus-
pected for HPV of diverse age group and ethnicity,
reporting various gynecological problems at three hospi-
tals including Nuclear Medicine, Oncology and Radio-
therapy Institute (NORI), Islamabad, Benazir Bhutto
Shaheed (BBS) Hospital, Rawalpindi and Nawaz Sharif
Medical College (NSMC), University of Gujrat, Gujrat,
were included. The study was approved by the ethical
committees at COMSATS Institute of Information
Technology (CIIT), NORI, BBS and NSMC. Cervical se-
cretion was collected after taking informed consents
from the patients with the help of gynecologist using
aseptic vaginal cotton swabs. DNA was extracted using a
novel CTAB-Guanidine thiocyanate method. Briefly,
0.5–1.0 ml of 2 % CTAB buffer (100 mM Tris-HCl
pH 8.0, 2 % (w/v) CTAB, 20 mM EDTA, 1.4 M NaCl,
and 1 % (v/v) β-mercaptoethanol) was added in the swab
container and homogenized using swab stick with cer-
vical secretion for 2–3 min, for maximum sample recov-
ery. About 0.5 ml of the mixture was transferred into
eppendorf tubes and was added with 0.5 ml of 4 M
guanidine thiocyanate solution and 0.7 ml of chloroform,
mixed thoroughly and centrifuged at 16,000 g for
10 min. 0.1 volume of 3 M sodium acetate was added to
Table 1 In-silico analysis of primers sets using BLAST for detection of high risk human papillomavirus types
Primer sets Sequence 5-′3′ Degenerate bases Tm (°C) Product
size (Kb)
Reference HPV Types
16 18 31 33 35 39 45 52 56 58 59
HRT1 F GACAGCGGRTATGGCAATWSTGAAG 3 56 ~1460 In this study + − + + + − − + − + −
HRT1 R CCACGTCCTTGAGAAAAAGGATTTCC 0
HRT2 F GAGACACACCWGARTGGATACA 2 56 ~1200 In this study − + − − − − + − + − −
HRT1 R CCATAGTTCCTCGCATGTRTCT 1
MY09 GCMCAGGGWCATAAYAATGG 3 45 ~450 [20] + + + + − + − − − + +
MY11 CGTCCMARRGGAWACTGATC 4
GP5 TTTGTTACTGGTAGATAC 0 40 ~140 [21] − − − − − − − − − − −
GP6 GAAAAATAAACTGTAAATCA 0
GP5+ TTTGTTACTGTGGTAGATACTAC 0 40 ~145 [22] + + + − − − + − − − −
GP6+ GAAAAATAAACTGTAAATCATATTC 0
CP65 CARGGTCAYAAYAATGGYAT 4 55 ~465 [23] x x x x x x x x x x x
CP70 AAYTTTCGTCCYARAGRAWATTGRTC 7
CP66 AATCARMTGTTTRTTACWGT 4 55 ~385 [23] x x x x x x x x x x x
CP69 GWTAGATCWACATYCCARAA 4
SPF1 GCICARGGICAYAAYAATGG 5 45 ~65 [24] x x x x x x x x x x x
SPF2 GTIGTATCIACWACAGTAACAAA 3
The non-redundant/nucleotide collection (nr) database at National Center of Biotechnology Information (NCBI at http://www.ncbi.nlm.nih.gov/) was searched with
the sequence of each primer by nucleotide Blast [27] using default values except maximum target sequences value was selected to 20,000. (+) means that both of
the primers in a pair have secured blast hits for a particular HPV types mentioned above, while (−) means that one or both of the primers in a set have not been
able to secure any blast hit for a particular HPV types. Due to the presence of many degenerate bases in the primer sequences, the Blast analysis was not been
successful for primer sets CP65 & CP70, CP66 & CP69 and SPF1 & SPF2 and is represented by (x). The GP6 primer showed no hit specific to HPV. The product sizes
are not exact and may differ slightly depending on the HPV types. The results in the table are based on Blast analysis only and may differ considerably compared
to published results or when used empirically, therefore, please refer to the given references for exact details of HPV types amplified by each primer set
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the supernatant and mixed which then followed by the
addition of isopropanol in equal quantity and centrifuga-
tion at 16,000 g for 5 min. After discarding the super-
natant, the DNA pellet was washed twice with 70 %
(v/v) ethanol and dissolved in 0.1× TAE Buffer containing
RNase. The appropriateness of DNA isolation was con-
firmed by PCR amplification of a fragment of human actin
beta gene from chromosome number 7 (accession number
NG_007992.1) using primer set {HACTB F: 5′-CACAG
TAGGTCTGAACAGACTC-3′ (position 6742-6763) and
HACTB R: 5′-AGTGATCTCCTTCTGCATCCTG-3′
(position 7568–7547) as positive control. The samples
were amplified with MY09/MY11 following procedure de-
scribed by Manos and colleagues [20], with GP5/GP6 fol-
lowing Snijders and colleagues [21], with GP5+/GP6+ as
described by de Roda Husman and colleagues [22], with
CP65/CP70, and CP66/CP69 following Berkhout and col-
leagues [23], and with SPF1/SPF2 as reported by Kleter
and colleagues [24].
Two novel primer sets HRT1 and HRT2 were devel-
oped by finding conserved regions in HPV genomes
using about 90 full-length genomic sequences belonging
to high risk HPV types 16, 18, 31, 33, 35, 45, 52, 56, 58,
59, 68 and 69 downloaded from GenBank and then
aligned using MAFFT version 6.864 [54] which utilizes
progressive and iterative refinement heuristic methods
for large genomic sequences. Depending upon the gen-
omic variability two sets of primers were designed i.e.
HRT1 {HRT1 F: 5′-GACAGCGGRTATGGCAATWST
GAAG-3′(position 1254–1278 of type 16 reference gen-
ome accession NC_001526.2) and HRT1 R: 5′-CCACGTC
CTTGAGAAAAAGGATTTCC-3′ (position 2714–2689
of type 16 reference genome accession NC_001526.2)
which can detect types 16, 31, 33, 35, 52 and 58 and
HRT2 {HRT2 F: 5′-GAGACACACCWGARTGGA
TACA-3′ (position 1935–1956 of type 18 reference gen-
ome accession NC_001357.1) and HRT2 R: 5′-CCA
TAGTTCCTCGCATGTRTCT-3′ (position 3134–3113 of
type 18 reference genome accession NC_001357.1) which
can detect types 18, 45, 56, 59, 68 and 69.
PCR reaction contained about 50 ng DNA template,
Taq buffer (10 mM Tris-HCl, pH 8.8, 50 mM KCl and
0.08 % (v/v) Nonidet P40) 1.5 mM MgCl2, 200 μM of
each dNTPs, 1.5 units Taq DNA Polymerase (recombin-
ant) (Fermentas, UAB Lithuania), and 50 pM of each
primer. The thermal profile for all primer sets included
pre-PCR denaturation at 96 °C for 3 min followed by
35 cycles of denaturing at 96 °C for 20 s, annealing at
56 °C for 20 s and extension at 72 °C for 2.5 min,
and a final extension at 72 °C for 20 min. The PCR
products were analyzed using standard 1 % agarose
gel electrophoresis.
The PCR product of HPV 16 isolate was cloned into
pTZ57R (InsTA Cloning Kit, Fermentas UAB Lithuania),
according to the manufacturer’s instructions, and trans-
formed into Escherichia coli DH5α cells by electropor-
ation. The cells were selected on ampicillin containing
Luria-Bertani (LB) agar plates and screened for β-
glucoronidase expression. Plasmid DNA was extracted
using a minipreparation protocol according to Sambrook
and Russell [55], and confirmed by digestion with re-
striction endonucleases. The plasmid DNA containing
cloned fragment from three different independent
clones, was sequenced using commercial sequencing fa-
cility of Macrogen (Korea) using M13 universal primers
and gene specific primers. The sequence data was com-
piled using DNA Dragon Sequence Assembler version
1.5.1 (Sequentix-Digital DNA Processing, Germany).
Phylogenetic analysis was performed on alignments
produced through MAFFT version 6.864 [54] to obtain
Neighbor-Joining (NJ) trees using Kimura’s two-parameter
model [56] implemented in in the Molecular Evolutionary
Genetics Analysis Program (MEGA) version 5.05 [57].
Phylogeny reconstruction test was performed using 1000
bootstrap replicates.
Conclusions
In conclusion, the study suggests the presence of HPV
in 3.26 % of cervical sample secretions analyzed from
Pakistani patients using two novel primer sets i.e. HRT1
and HRT2 developed by rigorous analysis of conserved
regions in a large data set of HPV genomes. Isolates
Pak01 and Pak02 originated from two female patients
belonging to different geographical regions were se-
quenced for the first time using HRT1 primer set and
their phylogenetic analysis suggests their belonging to
genus alpha 9 of HPV type-16. The reported primers
and sequence generated in this study will serve as foun-
dation for further epidemiological studies for HPV sur-
veillance in Pakistan.
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